The feasibility of dose escalation with three-dimensional conformal radiotherapy in patients with prostatic carcinoma.

The cancer journal from Scientific American

Volumn 1, Issue 2, 1995, Pages 142-150

  Zelefsky, M J ^a   Leibel, S A ^a   Kutcher, G J ^a   Kelson, S ^a   Ling, C C ^a   Fuks, Z ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADENOCARCINOMA; ARTICLE; BLOOD; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; FEASIBILITY STUDY; FOLLOW UP; HUMAN; MALE; MEGAVOLTAGE RADIOTHERAPY; PATHOLOGY; PHASE 1 CLINICAL TRIAL; PROSTATE TUMOR; RADIATION DOSE; RADIATION EXPOSURE; RADIATION RESPONSE; SEMINAL VESICLE; TREATMENT OUTCOME;

ADENOCARCINOMA; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEASIBILITY STUDIES; FOLLOW-UP STUDIES; HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, HIGH-ENERGY; SEMINAL VESICLES; TREATMENT OUTCOME;

EID: 33750105636     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)